TERADYNE, INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TERADYNE, INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.19B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.82B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $2.68B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $3.16B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $3.70B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $3.12B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $2.29B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $2.10B | Feb 22, 2021 |
| FY2017 | Dec 31, 2017 | $479.42M | Mar 1, 2018 |
| FY2017 | Oct 1, 2017 | $503.38M | Mar 1, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $758.97M | Feb 22, 2021 |
| FY2020 | Sep 27, 2020 | $819.48M | Feb 22, 2021 |
| FY2020 | Jun 28, 2020 | $838.66M | Feb 22, 2021 |
| FY2020 | Mar 31, 2020 | $494.10M | Feb 22, 2021 |
| FY2020 | Mar 29, 2020 | $704.36M | Feb 22, 2021 |
| FY2019 | Dec 31, 2019 | $654.65M | Mar 2, 2020 |
| FY2020 | Sep 30, 2019 | $582.04M | Feb 22, 2021 |
| FY2019 | Sep 29, 2019 | $582.04M | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | $564.18M | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $494.10M | Mar 2, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.86B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.65B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.54B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.87B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $2.21B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $449.79M | Feb 22, 2021 |
| FY2020 | Sep 27, 2020 | $458.93M | Feb 22, 2021 |
| FY2020 | Jun 28, 2020 | $471.47M | Feb 22, 2021 |
| FY2020 | Mar 29, 2020 | $405.55M | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | $383.24M | Feb 22, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $554.05M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $542.37M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $448.75M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $715.50M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.01B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $196.33M | Feb 22, 2021 |
| FY2020 | Sep 27, 2020 | $222.72M | Feb 22, 2021 |
| FY2020 | Jun 28, 2020 | $188.91M | Feb 22, 2021 |
| FY2020 | Mar 29, 2020 | $176.19M | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | $125.08M | Feb 22, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $650.05M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $593.79M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $501.07M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $831.94M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.20B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $234.08M | Feb 22, 2021 |
| FY2020 | Sep 27, 2020 | $269.66M | Feb 22, 2021 |
| FY2020 | Jun 28, 2020 | $217.95M | Feb 22, 2021 |
| FY2020 | Mar 29, 2020 | $206.72M | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | $171.66M | Feb 22, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $648.87M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $617.05M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $577.32M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $558.10M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $547.56M | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $124.28M | Feb 22, 2021 |
| FY2020 | Sep 27, 2020 | $115.84M | Feb 22, 2021 |
| FY2020 | Jun 28, 2020 | $113.26M | Feb 22, 2021 |
| FY2020 | Mar 29, 2020 | $111.39M | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | $117.09M | Feb 22, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $674.42M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $672.18M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $585.23M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $577.92M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.10B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $868.94M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $578.75M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $476.88M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $626.50M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $455.20M | Mar 1, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $224.01M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $198.10M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $159.64M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $163.25M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $132.47M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $184.98M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $134.64M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $114.38M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $105.38M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $85.27M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.18B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $3.71B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $3.49B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $3.50B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $3.81B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $3.65B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $2.79B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $2.71B | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $3.11B | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $2.76B | Mar 1, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.39B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $889.42M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $960.93M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.05B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.25B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $1.44B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $1.31B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $1.18B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $1.16B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $933.83M | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.80B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.82B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $2.53B | Feb 19, 2026 |
| FY2025 | Dec 31, 2022 | $2.45B | Feb 19, 2026 |
| FY2024 | Dec 31, 2021 | $2.56B | Feb 20, 2025 |
| FY2023 | Dec 31, 2020 | $2.21B | Feb 22, 2024 |
| FY2022 | Dec 31, 2019 | $1.48B | Feb 22, 2023 |
| FY2021 | Dec 31, 2018 | $1.52B | Feb 23, 2022 |
| FY2020 | Dec 31, 2017 | $1.95B | Feb 22, 2021 |
| FY2019 | Dec 31, 2016 | $1.83B | Mar 2, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $521.02M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $395.37M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $415.65M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $403.20M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $426.02M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $453.86M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $416.43M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $381.85M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $252.01M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $223.34M | Mar 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $744.44M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $970.76M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $706.51M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $725.73M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $736.57M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $387.41M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | ($241.92M) | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | ($158.19M) | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $272.01M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $230.29M | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $293.75M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $553.35M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $757.57M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $854.77M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.12B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $914.12M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $773.92M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $926.75M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $429.84M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $307.88M | Mar 1, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $0 | Feb 27, 2015 |
| FY2014 | Dec 31, 2013 | $0 | Feb 27, 2015 |
| FY2012 | Dec 31, 2012 | $171.06M | Mar 1, 2013 |
| FY2011 | Dec 31, 2011 | $159.96M | Feb 29, 2012 |
| FY2011 | Dec 31, 2010 | $150.18M | Feb 29, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 22, 2021 |
| FY2020 | Sep 27, 2020 | 1 | Feb 22, 2021 |
| FY2020 | Jun 28, 2020 | 1 | Feb 22, 2021 |
| FY2020 | Mar 29, 2020 | 1 | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 22, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 22, 2021 |
| FY2020 | Sep 27, 2020 | 1 | Feb 22, 2021 |
| FY2020 | Jun 28, 2020 | 1 | Feb 22, 2021 |
| FY2020 | Mar 29, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 22, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 156.09M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 161.72M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | 152.70M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | 155.76M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 162.25M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | 166,123 | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | 166.41M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | 175.52M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 195.55M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 199.18M | Mar 1, 2018 |